Risk factors for local atypical fibroxanthoma recurrence and progression to pleomorphic dermal sarcoma: A meta-analysis of individualized participant data
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
Risk factors for local atypical fibroxanthoma recurrence and progression to pleomorphic dermal sarcoma : A meta-analysis of individualized participant data. / Ørholt, Mathias; Aaberg, Frederik L; Abebe, Kiya; Walsh, S; Roenigk, Randall K; Venzo, Alessandro; Schmidt, Grethe; Klyver, Helle; Jensen, David H; Herly, Mikkel; Vester-Glowinski, Peter V.
I: Journal of Surgical Oncology, Bind 126, Nr. 3, 2022, s. 555-562.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Risk factors for local atypical fibroxanthoma recurrence and progression to pleomorphic dermal sarcoma
T2 - A meta-analysis of individualized participant data
AU - Ørholt, Mathias
AU - Aaberg, Frederik L
AU - Abebe, Kiya
AU - Walsh, S
AU - Roenigk, Randall K
AU - Venzo, Alessandro
AU - Schmidt, Grethe
AU - Klyver, Helle
AU - Jensen, David H
AU - Herly, Mikkel
AU - Vester-Glowinski, Peter V
N1 - © 2022 The Authors. Journal of Surgical Oncology published by Wiley Periodicals LLC.
PY - 2022
Y1 - 2022
N2 - BACKGROUND: Risk factors for local atypical fibroxanthoma (AFX) recurrence and progression to pleomorphic dermal sarcoma (PDS) have not previously been identified.OBJECTIVE: To identify risk factors and provide follow-up suggestions for local AFX recurrence and progression to PDS.METHODS AND MATERIALS: A literature search was performed in the PubMed, EMBASE, and Cochrane databases. The PRISMA and MOOSE guidelines were followed. The risks of local AFX recurrence and progression to PDS were presented as Kaplan-Meier plots and risk factors were presented as hazard ratios (HRs) calculated with univariate and multivariate Cox regression.RESULTS: Five hundred and ninety-eight patients with AFX from 14 studies were included. Age >74 years and male sex significantly increased the risk of local recurrence (HR: 7.31 [95% confidence interval [CI]: 1.78-30.0], p < 0.01 and HR: 2.89 [95% CI: 1.04-8.01], p < 0.05, respectively). There was no difference when comparing wide local excision and Mohs' micrographic surgery (p = 0.89). The risks of local AFX recurrence and progression to PDS after 2 years were <1%.CONCLUSION: A more intensive follow-up regimen could be considered in patients >74 years old and males due to the higher risk of local AFX recurrence.
AB - BACKGROUND: Risk factors for local atypical fibroxanthoma (AFX) recurrence and progression to pleomorphic dermal sarcoma (PDS) have not previously been identified.OBJECTIVE: To identify risk factors and provide follow-up suggestions for local AFX recurrence and progression to PDS.METHODS AND MATERIALS: A literature search was performed in the PubMed, EMBASE, and Cochrane databases. The PRISMA and MOOSE guidelines were followed. The risks of local AFX recurrence and progression to PDS were presented as Kaplan-Meier plots and risk factors were presented as hazard ratios (HRs) calculated with univariate and multivariate Cox regression.RESULTS: Five hundred and ninety-eight patients with AFX from 14 studies were included. Age >74 years and male sex significantly increased the risk of local recurrence (HR: 7.31 [95% confidence interval [CI]: 1.78-30.0], p < 0.01 and HR: 2.89 [95% CI: 1.04-8.01], p < 0.05, respectively). There was no difference when comparing wide local excision and Mohs' micrographic surgery (p = 0.89). The risks of local AFX recurrence and progression to PDS after 2 years were <1%.CONCLUSION: A more intensive follow-up regimen could be considered in patients >74 years old and males due to the higher risk of local AFX recurrence.
KW - Bone Neoplasms/surgery
KW - Histiocytoma, Malignant Fibrous
KW - Humans
KW - Male
KW - Mohs Surgery/adverse effects
KW - Neoplasm Recurrence, Local/epidemiology
KW - Risk Factors
KW - Skin Neoplasms/surgery
U2 - 10.1002/jso.26898
DO - 10.1002/jso.26898
M3 - Journal article
C2 - 35441377
VL - 126
SP - 555
EP - 562
JO - Journal of Surgical Oncology
JF - Journal of Surgical Oncology
SN - 0022-4790
IS - 3
ER -
ID: 345422992